Results 161 to 170 of about 123,237 (299)

[No Title]

British Journal of Psychiatry, 1996
J. Laugharne, J. Arcelsus, A. Davies, PA. Corrmt, P. Raven   +4 more
semanticscholar   +1 more source

Lower social participation and physical activity in patients with craniopharyngioma or CNS germ cell tumor: Their association with apathy

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 3, September 2026.
Abstract Aim This study aimed to compare social participation and physical activity in patients with craniopharyngioma or central nervous system germ cell tumor (CNS germ cell tumor) with those of healthy participants and examine their associations with social behavioral disorders.
Misa Komaki, Yoshiki Arakawa, Keita Ueda, Katsutsugu Umeda, Tsukasa Ueno, Masahiro Tanji, Yohei Mineharu, Takeshi Funaki, Takayuki Kikuchi, Toshiya Murai, Ami Tabata   +10 more
wiley   +1 more source

Is it Possible to Have Coexisting Exogenous and Endogenous Cushing's Syndrome? [PDF]

Cureus
Rafi S, El Idrissi Dfali N, Elmghari G, El Ansari N.   +3 more
europepmc   +1 more source

Obesity in Classic Congenital Adrenal Hyperplasia: Mechanisms, Complications and Management

Clinical Endocrinology, Volume 105, Issue 3, Page 271-284, September 2026.
ABSTRACT Classic congenital adrenal hyperplasia (CCAH) is an autosomal recessive genetic disorder primarily caused by 21‐hydroxylase deficiency. Although the survival rate of patients has significantly improved with glucocorticoid replacement therapy, long‐term use of supraphysiological doses and multiple factors inherent to the disease itself have led
Jialin Mu, Yue Li, Meng Sun, Yulin Li, Panpan Li, Hui Zou   +5 more
wiley   +1 more source

Cushing disease and unilateral primary aldosteronism confounded by a nonfunctioning contralateral adrenal incidentaloma. [PDF]

JCEM Case Rep
Friedman J, Jamshidi P, Huang W.
europepmc   +1 more source

In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.

Endocrinology, 1996
E. Webster, D. Lewis, D. J. Torpy, E. Zachman, K. C. Rice, G. Chrousos   +5 more
semanticscholar   +1 more source

Gut microbiota dynamics and its impact on the efficacy of ACTH therapy in infantile epileptic spasms syndrome. [PDF]

Front Neurol
Zhang X, Hu X, Hao X, Zhang H, Tao Z, Liang J.   +5 more
europepmc   +1 more source

Neurodevelopmental Phenotypes and Brain Anomalies in Individuals With Heterozygous SEMA6A Variants

Clinical Genetics, Volume 110, Issue 3, Page 325-335, September 2026.
SEMA6A plays a role in cell migration and axon guidance in the developing central nervous system. Phenotypes seen in eleven individuals heterozygous for SEMA6A variants included developmental delay, intellectual disability, autism/autistic behaviors, behavioral abnormalities, attention disorders, hypotonia, and brain anomalies.
Evan Burchfiel, Xiaonan Zhao, Nichole M. Owen, Tia Gordon, Mahshid S. Azamian, Eric C. Kao, Fan Xia, Xi Luo, Jill A. Rosenfeld, Seema R. Lalani, Allison P. Ortega, Steven B. Bleyl, Florence Petit, Sulekha Rajagopolan, Bénédicte Demeer, Meredith K. Gillespie, Lijia Huang, Matthew Osmond, Kym M. Boycott, Kyra E. Stuurman, Marjon A. van Slegtenhorst, Haley Soller, Céline Jost, Aurore Garde, Hana Safraou, Laurence Faivre, Victor Faundes, Daryl A. Scott   +27 more
wiley   +1 more source

Hidden in the Mediastinum: A Grade 1 Neuroendocrine Tumor Revealed by Refractory Hypokalemia and Ectopic Adrenocorticotropic Hormone (ACTH)-Dependent Cushing's Syndrome. [PDF]

Cureus
Agüero-Pineda SP, Grimaldo-Rivera R, Camacho-Muñoz JA, Martínez-Navarro AT, Landeros-Navarro E, Ramírez-Ochoa S, Zúñiga-García MÁ, Zúñiga-Tamayo DA, Rubio-Martín Del Campo M, Vicente-Hernández B, Cervantes-Pérez E.   +10 more
europepmc   +1 more source

ACTH suppression and adverse effects of cabergoline in horses with pituitary pars intermedia dysfunction

Equine Veterinary Education, Volume 38, Issue 9, Page e622-e630, September 2026.
Summary Background The diagnosis and management of pituitary pars intermedia dysfunction (PPID) in horses includes evaluating abnormal plasma concentrations of adrenocorticotrophic hormone (ACTH). Treatment commonly includes the oral dopamine agonist pergolide mesylate, which suppresses the pathologic overproduction of ACTH.
A. Bracken, H. Tyra, M. Vetter, K. Kiger, S. Rao, L. Bass   +5 more
wiley   +1 more source